629 related articles for article (PubMed ID: 28807908)
1. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii.
Vázquez-Ucha JC; Martínez-Guitián M; Maneiro M; Conde-Pérez K; Álvarez-Fraga L; Torrens G; Oliver A; Buynak JD; Bonomo RA; Bou G; González-Bello C; Poza M; Beceiro A
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383666
[TBL] [Abstract][Full Text] [Related]
3. C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major
Stewart NK; Toth M; Alqurafi MA; Chai W; Nguyen TQ; Quan P; Lee M; Buynak JD; Smith CA; Vakulenko SB
mBio; 2022 Jun; 13(3):e0036722. PubMed ID: 35420470
[TBL] [Abstract][Full Text] [Related]
4. Targeting Multidrug-Resistant
Barnes MD; Kumar V; Bethel CR; Moussa SH; O'Donnell J; Rutter JD; Good CE; Hujer KM; Hujer AM; Marshall SH; Kreiswirth BN; Richter SS; Rather PN; Jacobs MR; Papp-Wallace KM; van den Akker F; Bonomo RA
mBio; 2019 Mar; 10(2):. PubMed ID: 30862744
[TBL] [Abstract][Full Text] [Related]
5. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Mushtaq S; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
[TBL] [Abstract][Full Text] [Related]
6. LN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48.
Vallejo JA; Martínez-Guitián M; Vázquez-Ucha JC; González-Bello C; Poza M; Buynak JD; Bethel CR; Bonomo RA; Bou G; Beceiro A
J Antimicrob Chemother; 2016 Aug; 71(8):2171-80. PubMed ID: 27125555
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase.
Smith CA; Stewart NK; Toth M; Vakulenko SB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358584
[TBL] [Abstract][Full Text] [Related]
8. Active-Site Plasticity Is Essential to Carbapenem Hydrolysis by OXA-58 Class D β-Lactamase of Acinetobacter baumannii.
Pratap S; Katiki M; Gill P; Kumar P; Golemi-Kotra D
Antimicrob Agents Chemother; 2016 Jan; 60(1):75-86. PubMed ID: 26459904
[TBL] [Abstract][Full Text] [Related]
9. Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.
Nowak P; Paluchowska P
Folia Histochem Cytobiol; 2016; 54(2):61-74. PubMed ID: 27270503
[TBL] [Abstract][Full Text] [Related]
10. Class D β-lactamases: are they all carbapenemases?
Antunes NT; Lamoureaux TL; Toth M; Stewart NK; Frase H; Vakulenko SB
Antimicrob Agents Chemother; 2014; 58(4):2119-25. PubMed ID: 24468778
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking, dynamics and free energy analyses of
Ramachandran B; Jeyakanthan J; Lopes BS
J Med Microbiol; 2020 Aug; 69(8):1062-1078. PubMed ID: 32773005
[No Abstract] [Full Text] [Related]
12. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
Monogue ML; Sakoulas G; Nizet V; Nicolau DP
Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.
Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD
ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838
[TBL] [Abstract][Full Text] [Related]
14. Penicillin sulfone inhibitors of class D beta-lactamases.
Drawz SM; Bethel CR; Doppalapudi VR; Sheri A; Pagadala SR; Hujer AM; Skalweit MJ; Anderson VE; Chen SG; Buynak JD; Bonomo RA
Antimicrob Agents Chemother; 2010 Apr; 54(4):1414-24. PubMed ID: 20086146
[TBL] [Abstract][Full Text] [Related]
15. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
Tiwari V; Kapil A; Moganty RR
Microb Pathog; 2012 Aug; 53(2):81-6. PubMed ID: 22610043
[TBL] [Abstract][Full Text] [Related]
17. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.
Afzal-Shah M; Woodford N; Livermore DM
Antimicrob Agents Chemother; 2001 Feb; 45(2):583-8. PubMed ID: 11158758
[TBL] [Abstract][Full Text] [Related]
18. Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant
Zalacain M; Achard P; Llanos A; Morrissey I; Hawser S; Holden K; Toomey E; Davies D; Leiris S; Sable C; Ledoux A; Bousquet J; Castandet J; Lozano C; Everett M; Lemonnier M
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0112023. PubMed ID: 38289044
[TBL] [Abstract][Full Text] [Related]
19. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
Poirel L; Marqué S; Héritier C; Segonds C; Chabanon G; Nordmann P
Antimicrob Agents Chemother; 2005 Jan; 49(1):202-8. PubMed ID: 15616297
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
